Kodiak Sciences Inc - Company Profile

Powered by

All the sales intelligence you need on Kodiak Sciences Inc in one solution.

$195 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Kodiak Sciences Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Kodiak Sciences Inc.

Back to companies

Kodiak Sciences Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Kodiak Sciences Inc (Kodiak Sciences) is a biopharmaceutical company focused on the research, development, and commercialization of therapeutics for retinal diseases. Its pipeline products include Tarcocimab, an anti-vascular endothelial growth factor (VEGF) which treats Diabetic retinopathy, Wet age-related macular degeneration, Retinal vein occlusion; KSI-501 targets Wet age-related macular degeneration and Diabetic macular edema; and KSI-101 for macular edema secondary to inflammation. The company leverages antibody biopolymer conjugate drug platform for the generation of retinal medicines. It operates in the US, and Switzerland. Kodiak Sciences is headquartered in Palo Alto, California, the US.

 Gain a 360-degree view of Kodiak Sciences Inc and make more informed decisions for your business Gain a 360-degree view of Kodiak Sciences Inc and make more informed decisions for your business Learn more
Headquarters United States of America
Address 1250 Page Mill Road, Palo Alto, California, 94304
Website www.kodiak.com/
Telephone 1 650 2810850
No of Employees 124
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange KOD (NASD)
EPS XYZ
Net Income (2024) XYZ -30.5% (2024 vs 2023)
Market Cap* $2.4B
   
   
* As of and is in US$
View Kodiak Sciences Inc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Learn more

Kodiak Sciences Inc premium industry data and analytics

50+

Catalyst Calendar

Proactively evaluate Kodiak Sciences Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

40+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Kodiak Sciences Inc’s relevant decision makers and contact details.

10+

Clinical Trials

Determine Kodiak Sciences Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

7

Pipeline Drugs

Identify which of Kodiak Sciences Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

3

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

1

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

Products and Services

Products Brands
Pipeline Zenkuda
Tarcocimab:
Diabetic Retinopathy
XYZ
XYZ
XYZ
Understand Kodiak Sciences Inc portfolio and identify potential areas for collaboration Understand Kodiak Sciences Inc portfolio and identify potential areas for collaboration Learn more
Image for loader

Competitor Comparison

Key Parameters Kodiak Sciences Inc Clearside BioMedical Inc Adverum Biotechnologies Inc Aldeyra Therapeutics Inc Genentech Inc
Headquarters United States of America United States of America United States of America United States of America United States of America
City Palo Alto Alpharetta Redwood City Lexington San Francisco
State/Province California Georgia California Massachusetts California
No. of Employees 124 32 - 8 13,500
Entity Type Public Public Private Public Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Learn more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Learn more
Executives
Name Position Board Since Age
Victor Perlroth, M.D Chairman; Chief Executive Officer Executive Board 2009 53
John A. Borgeson Chief Financial Officer; Executive Vice President; Secretary Senior Management 2016 64
Pablo Velazquez-Martin, M.D Chief Medical Officer Senior Management - -
Dolly S. Chang, M.D, Ph.D Chief Scientific Officer Senior Management 2024 -
Gorton Chiu Vice President - Finance Senior Management 2020 -
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Kodiak Sciences Inc key executives to enhance your sales strategy Gain insight into Kodiak Sciences Inc key executives to enhance your sales strategy Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?